219
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Application and Evaluation of Metagenomic Next-Generation Sequencing in Pulmonary Infection with Pleural Effusion

, , , , , , & show all
Pages 2813-2824 | Published online: 01 Jun 2022

References

  • Nayak R, Brogly SB, Lajkosz K, et al. Two decades of thoracic empyema in Ontario, Canada. Chest. 2020;157:1114–1116. doi:10.1016/j.chest.2019.11.040
  • Grijalva CG, Zhu Y, Nuorti JP, et al. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66:663–668. doi:10.1136/thx.2010.156406
  • Bobbio A, Bouam S, Frenkiel J, et al. Epidemiology and prognostic factors of pleural empyema. Thorax. 2021;76:1117–1123. doi:10.1136/thoraxjnl-2020-215267
  • Lehtomäki A, Nevalainen R, Ukkonen M, et al. Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish University Hospital. Scand J Surg. 2020;109:127–132. doi:10.1177/1457496919832146
  • Shen HN, Lu CL, Li CY. Epidemiology of pleural infections in Taiwan from 1997 through 2008. Respirology. 2012;17:1086–1093. doi:10.1111/j.1440-1843.2012.02214.x
  • Dean NC, Griffith PP, Sorensen JS, et al. Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia. Chest. 2016;149:1509–1515. doi:10.1016/j.chest.2015.12.027
  • Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64:592–597. doi:10.1136/thx.2008.105080
  • Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54:1900542. doi:10.1183/13993003.00542-2019
  • Sziklavari Z, Graml JI, Zeman F, et al. [Outcomes of stage-adapted surgical treatment of pleural empyema]. Zentralbl Chir. 2016;141:335–340. German. doi:10.1055/s-0041-109703
  • Jany B, Welte T. Pleural effusion in adults-etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2019;116:377–386. doi:10.3238/arztebl.2019.0377
  • Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565–1577. doi:10.1086/509330
  • Zhou G, Zhou Y, Zhong C, et al. Retrospective analysis of 1641 cases of classic fever of unknown origin. Ann Transl Med. 2020;8:690. doi:10.21037/atm-20-3875
  • Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. 2007;30:S7–15. doi:10.1016/j.ijantimicag.2007.06.024
  • Tattevin P, Watt G, Revest M, et al. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45:1–8. doi:10.1016/j.medmal.2014.11.003
  • Pallen MJ. Diagnostic metagenomics: potential applications to bacterial, viral and parasitic infections. Parasitology. 2014;141:1856–1862. doi:10.1017/S0031182014000134
  • Han D, Li Z, Li R, et al. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019;45:668–685. doi:10.1080/1040841X.2019.1681933
  • Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66:778–788. doi:10.1093/cid/cix881
  • Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67:S231–S240. doi:10.1093/cid/ciy693
  • Goldberg B, Sichtig H, Geyer C, et al. Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics. mBio. 2015;6:e01888–15. doi:10.1128/mBio.01888-15
  • Li N, Cai Q, Miao Q, et al. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5:2000792. doi:10.1002/smtd.202000792
  • Filkins LM, Bryson AL, Miller SA, et al. Navigating clinical utilization of direct-from-specimen metagenomic pathogen detection: clinical applications, limitations, and testing recommendations. Clin Chem. 2020;66:1381–1395. doi:10.1093/clinchem/hvaa183
  • Zhang HC, Ai JW, Cui P, et al. Incremental value of metagenomic next generation sequencing for the diagnosis of suspected focal infection in adults. J Infect. 2019;79:419–425. doi:10.1016/j.jinf.2019.08.012
  • Zhang XX, Guo LY, Liu LL, et al. The diagnostic value of metagenomic next-generation sequencing for identifying Streptococcus pneumoniae in paediatric bacterial meningitis. BMC Infect Dis. 2019;19:495. doi:10.1186/s12879-019-4132-y
  • van Rijn AL, van Boheemen S, Sidorov I, et al. The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease. PLoS One. 2019;14:e0223952. doi:10.1371/journal.pone.0223952
  • Li G, Huang J, Li Y, et al. The value of combined radial endobronchial ultrasound-guided transbronchial lung biopsy and metagenomic next-generation sequencing for peripheral pulmonary infectious lesions. Can Respir J. 2020;2020:2367505. doi:10.1155/2020/2367505
  • Huang J, Jiang E, Yang D, et al. Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions. Infect Drug Resist. 2020;13:567–576. doi:10.2147/IDR.S235182
  • Yang W, Zhang B, Zhang ZM. Infectious pleural effusion status and treatment progress. J Thorac Dis. 2017;9:4690–4699. doi:10.21037/jtd.2017.10.96
  • Birkenkamp K, O’Horo JC, Kashyap R, et al. Empyema management: a cohort study evaluating antimicrobial therapy. J Infect. 2016;72:537–543. doi:10.1016/j.jinf.2016.02.009
  • Krenke K, Urbankowska E, Urbankowski T, et al. Clinical characteristics of 323 children with parapneumonic pleural effusion and pleural empyema due to community acquired pneumonia. J Infect Chemother. 2016;22:292–297. doi:10.1016/j.jiac.2016.01.016
  • Meyer CN, Rosenlund S, Nielsen J, et al. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis. 2011;43:165–169. doi:10.3109/00365548.2010.536162
  • Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518–526. doi:10.1056/NEJMoa1012740
  • Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis. 2011;53:254–261. doi:10.1093/cid/cir354
  • Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174:817–823. doi:10.1164/rccm.200601-074OC
  • Walls G, McBride S, Raymond N, et al. Infective endocarditis in New Zealand: data from the international collaboration on endocarditis prospective cohort study. N Z Med J. 2014;127:38–51.
  • Facklam RR. Physiological differentiation of viridans streptococci. J Clin Microbiol. 1977;5:184–201. doi:10.1128/jcm.5.2.184-201.1977
  • Porcel JM. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med. 2010;16:357–361. doi:10.1097/MCP.0b013e328338a108
  • Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med. 2008;14:310–315. doi:10.1097/MCP.0b013e3282fd0d9b
  • Psallidas I, Corcoran JP, Rahman NM. Management of parapneumonic effusions and empyema. Semin Respir Crit Care Med. 2014;35:715–722. doi:10.1055/s-0034-1395503
  • Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19:252. doi:10.1186/s12890-019-1022-4
  • Xie G, Zhao B, Wang X, et al. Exploring the clinical utility of metagenomic next-generation sequencing in the diagnosis of pulmonary infection. Infect Dis Ther. 2021;10:1419–1435. doi:10.1007/s40121-021-00476-w
  • Legoff J, Zucman N, Lemiale V, et al. Clinical significance of upper airway virus detection in critically ill hematology patients. Am J Respir Crit Care Med. 2019;199:518–528. doi:10.1164/rccm.201804-0681OC
  • Li F, Yuan MZ, Wang L, et al. Characteristics and prognosis of pulmonary infection in patients with neurologic disease and hypoproteinemia. Expert Rev Anti Infect Ther. 2015;13:521–526. doi:10.1586/14787210.2015.1019471
  • Xu S, Du B, Shan A, et al. The risk factors for the postoperative pulmonary infection in patients with hypertensive cerebral hemorrhage: a retrospective analysis. Medicine. 2020;99:e23544. doi:10.1097/MD.0000000000023544
  • Wang J, Zu Q, Wang W. Analysis of factors of pulmonary fungal infection in mice in respiratory medicine department based on logistic regression analysis model and Progranulin. Saudi J Biol Sci. 2020;27:629–635. doi:10.1016/j.sjbs.2019.12.001